FOLD logo

Amicus Therapeutics, Inc. (FOLD) Operating Profit

Annual Operating Profit:

$34.06M+$107.56M(+146.35%)
December 31, 2024

Summary

  • As of today, FOLD annual operating income is $34.06 million, with the most recent change of +$107.56 million (+146.35%) on December 31, 2024.
  • During the last 3 years, FOLD annual operating profit has risen by +$233.98 million (+117.04%).
  • FOLD annual operating profit is now at all-time high.

Performance

FOLD Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDincome statement metrics

Quarterly Operating Profit:

-$7.77M+$180.00K(+2.26%)
June 30, 2025

Summary

  • As of today, FOLD quarterly operating income is -$7.77 million, with the most recent change of +$180.00 thousand (+2.26%) on June 30, 2025.
  • Over the past year, FOLD quarterly operating profit has dropped by -$22.74 million (-151.93%).
  • FOLD quarterly operating profit is now -122.55% below its all-time high of $34.46 million, reached on December 31, 2009.

Performance

FOLD Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDincome statement metrics

TTM Operating Profit:

$25.05M-$22.74M(-47.58%)
June 30, 2025

Summary

  • As of today, FOLD TTM operating income is $25.05 million, with the most recent change of -$22.74 million (-47.58%) on June 30, 2025.
  • Over the past year, FOLD TTM operating profit has increased by +$50.48 million (+198.51%).
  • FOLD TTM operating profit is now -47.58% below its all-time high of $47.79 million, reached on March 31, 2025.

Performance

FOLD TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

FOLD Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+146.3%-151.9%+198.5%
3Y3 Years+117.0%+87.2%+110.4%
5Y5 Years+111.3%+84.7%+109.3%

FOLD Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+116.7%-131.3%+80.9%-47.6%+110.7%
5Y5-Yearat high+111.3%-131.3%+89.0%-47.6%+109.3%
All-TimeAll-Timeat high+110.5%-122.5%+95.0%-47.6%+106.6%

FOLD Operating Profit History

DateAnnualQuarterlyTTM
Jun 2025
-
-$7.77M(+2.3%)
$25.05M(-47.6%)
Mar 2025
-
-$7.95M(-149.8%)
$47.79M(+40.3%)
Dec 2024
$34.06M(+146.3%)
$15.97M(-35.6%)
$34.06M(+136.5%)
Sep 2024
-
$24.80M(+65.7%)
$14.40M(+156.6%)
Jun 2024
-
$14.97M(+169.0%)
-$25.43M(+56.0%)
Mar 2024
-
-$21.68M(-487.1%)
-$57.78M(+21.4%)
Dec 2023
-$73.49M(+64.0%)
-$3.69M(+75.4%)
-$73.49M(+33.5%)
Sep 2023
-
-$15.03M(+13.6%)
-$110.55M(+14.2%)
Jun 2023
-
-$17.39M(+53.5%)
-$128.79M(+25.1%)
Mar 2023
-
-$37.38M(+8.2%)
-$171.90M(+15.9%)
Dec 2022
-$204.43M(-2.3%)
-$40.74M(-22.5%)
-$204.43M(+12.7%)
Sep 2022
-
-$33.27M(+45.0%)
-$234.09M(+2.4%)
Jun 2022
-
-$60.50M(+13.5%)
-$239.93M(-10.4%)
Mar 2022
-
-$69.91M(+0.7%)
-$217.25M(-8.7%)
Dec 2021
-$199.92M(+18.0%)
-$70.41M(-80.0%)
-$199.92M(-3.1%)
Sep 2021
-
-$39.11M(-3.4%)
-$193.88M(+6.1%)
Jun 2021
-
-$37.81M(+28.1%)
-$206.50M(+5.8%)
Mar 2021
-
-$52.58M(+18.3%)
-$219.31M(+10.1%)
Dec 2020
-$243.85M(+18.9%)
-$64.37M(-24.4%)
-$243.85M(+9.0%)
Sep 2020
-
-$51.73M(-2.2%)
-$267.86M(+1.8%)
Jun 2020
-
-$50.63M(+34.4%)
-$272.65M(+8.5%)
Mar 2020
-
-$77.13M(+12.7%)
-$297.97M(+0.9%)
Dec 2019
-$300.74M(+7.6%)
-$88.38M(-56.4%)
-$300.74M(-6.9%)
Sep 2019
-
-$56.52M(+25.6%)
-$281.25M(+25.9%)
Jun 2019
-
-$75.95M(+4.9%)
-$379.61M(-8.4%)
Mar 2019
-
-$79.90M(-16.0%)
-$350.29M(-7.6%)
Dec 2018
-$325.48M(-60.8%)
-$68.88M(+55.5%)
-$325.48M(-1.7%)
Sep 2018
-
-$154.88M(-232.1%)
-$319.97M(-46.0%)
Jun 2018
-
-$46.63M(+15.3%)
-$219.15M(-0.3%)
Mar 2018
-
-$55.08M(+13.1%)
-$218.53M(-3.6%)
Dec 2017
-$202.38M(-20.1%)
-$63.38M(-17.2%)
-$210.88M(-7.9%)
Sep 2017
-
-$54.05M(-17.5%)
-$195.38M(-2.6%)
Jun 2017
-
-$46.01M(+3.0%)
-$190.36M(-4.2%)
Mar 2017
-
-$47.44M(+0.9%)
-$182.70M(-4.4%)
Dec 2016
-$168.56M(-37.1%)
-$47.88M(+2.4%)
-$175.06M(-4.7%)
Sep 2016
-
-$49.04M(-27.9%)
-$167.28M(-9.9%)
Jun 2016
-
-$38.35M(+3.6%)
-$152.18M(-8.9%)
Mar 2016
-
-$39.80M(+0.7%)
-$139.70M(-13.6%)
Dec 2015
-$122.94M
-$40.09M(-18.1%)
-$122.94M(-17.8%)
DateAnnualQuarterlyTTM
Sep 2015
-
-$33.94M(-31.2%)
-$104.34M(-18.8%)
Jun 2015
-
-$25.86M(-12.2%)
-$87.80M(-14.6%)
Mar 2015
-
-$23.05M(-7.3%)
-$76.59M(-11.5%)
Dec 2014
-$68.66M(-11.3%)
-$21.49M(-23.5%)
-$68.66M(-13.5%)
Sep 2014
-
-$17.40M(-18.8%)
-$60.48M(-3.9%)
Jun 2014
-
-$14.65M(+3.1%)
-$58.21M(+2.3%)
Mar 2014
-
-$15.12M(-13.7%)
-$59.57M(+3.4%)
Dec 2013
-$61.69M(-17.9%)
-$13.30M(+12.1%)
-$61.69M(+3.5%)
Sep 2013
-
-$15.13M(+5.4%)
-$63.91M(+2.7%)
Jun 2013
-
-$16.00M(+7.2%)
-$65.69M(-11.3%)
Mar 2013
-
-$17.25M(-11.1%)
-$59.04M(-12.4%)
Dec 2012
-$52.33M(-2.8%)
-$15.52M(+8.2%)
-$52.53M(-5.0%)
Sep 2012
-
-$16.92M(-81.0%)
-$50.04M(-8.3%)
Jun 2012
-
-$9.35M(+13.0%)
-$46.20M(+10.4%)
Mar 2012
-
-$10.74M(+17.5%)
-$51.58M(-1.5%)
Dec 2011
-$50.89M(+8.9%)
-$13.03M(+0.4%)
-$50.83M(+6.5%)
Sep 2011
-
-$13.08M(+11.2%)
-$54.34M(+0.3%)
Jun 2011
-
-$14.72M(-47.3%)
-$54.52M(-3.9%)
Mar 2011
-
-$10.00M(+39.5%)
-$52.49M(+6.0%)
Dec 2010
-$55.84M(-858.1%)
-$16.54M(-24.7%)
-$55.84M(-1054.4%)
Sep 2010
-
-$13.27M(-4.6%)
-$4.84M(+4.1%)
Jun 2010
-
-$12.69M(+5.0%)
-$5.05M(+18.8%)
Mar 2010
-
-$13.35M(-138.7%)
-$6.21M(-6.5%)
Dec 2009
-$5.83M(+86.7%)
$34.46M(+355.8%)
-$5.83M(+89.4%)
Sep 2009
-
-$13.47M(+2.7%)
-$55.17M(-8.2%)
Jun 2009
-
-$13.85M(-6.8%)
-$51.00M(-7.1%)
Mar 2009
-
-$12.97M(+12.8%)
-$47.64M(-8.4%)
Dec 2008
-$43.96M(+4.0%)
-$14.88M(-60.0%)
-$43.96M(-3.3%)
Sep 2008
-
-$9.30M(+11.4%)
-$42.56M(+5.6%)
Jun 2008
-
-$10.49M(-13.0%)
-$45.07M(-0.5%)
Mar 2008
-
-$9.29M(+31.1%)
-$44.86M(+2.1%)
Dec 2007
-$45.80M(+2.2%)
-$13.48M(-14.2%)
-$45.81M(-41.7%)
Sep 2007
-
-$11.81M(-14.8%)
-$32.32M(-57.5%)
Jun 2007
-
-$10.28M(-0.5%)
-$20.52M(-100.5%)
Mar 2007
-
-$10.23M
-$10.23M
Dec 2006
-$46.86M(-124.9%)
-
-
Dec 2005
-$20.83M(-144.3%)
-
-
Dec 2004
-$8.53M(-53.1%)
-
-
Dec 2003
-$5.57M
-
-

FAQ

  • What is Amicus Therapeutics, Inc. annual operating income?
  • What is the all-time high annual operating profit for Amicus Therapeutics, Inc.?
  • What is Amicus Therapeutics, Inc. annual operating profit year-on-year change?
  • What is Amicus Therapeutics, Inc. quarterly operating income?
  • What is the all-time high quarterly operating profit for Amicus Therapeutics, Inc.?
  • What is Amicus Therapeutics, Inc. quarterly operating profit year-on-year change?
  • What is Amicus Therapeutics, Inc. TTM operating income?
  • What is the all-time high TTM operating profit for Amicus Therapeutics, Inc.?
  • What is Amicus Therapeutics, Inc. TTM operating profit year-on-year change?

What is Amicus Therapeutics, Inc. annual operating income?

The current annual operating profit of FOLD is $34.06M

What is the all-time high annual operating profit for Amicus Therapeutics, Inc.?

Amicus Therapeutics, Inc. all-time high annual operating income is $34.06M

What is Amicus Therapeutics, Inc. annual operating profit year-on-year change?

Over the past year, FOLD annual operating income has changed by +$107.56M (+146.35%)

What is Amicus Therapeutics, Inc. quarterly operating income?

The current quarterly operating profit of FOLD is -$7.77M

What is the all-time high quarterly operating profit for Amicus Therapeutics, Inc.?

Amicus Therapeutics, Inc. all-time high quarterly operating income is $34.46M

What is Amicus Therapeutics, Inc. quarterly operating profit year-on-year change?

Over the past year, FOLD quarterly operating income has changed by -$22.74M (-151.93%)

What is Amicus Therapeutics, Inc. TTM operating income?

The current TTM operating profit of FOLD is $25.05M

What is the all-time high TTM operating profit for Amicus Therapeutics, Inc.?

Amicus Therapeutics, Inc. all-time high TTM operating income is $47.79M

What is Amicus Therapeutics, Inc. TTM operating profit year-on-year change?

Over the past year, FOLD TTM operating income has changed by +$50.48M (+198.51%)
On this page